NCT06098456View on ClinicalTrials.gov

Epigallocatechin Gallate and Other Antural Compounds in HPV Infections

PHASE2CompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

May 15, 2024

Study Completion Date

June 28, 2024

Conditions
Papilloma-induced Cervical Lesions
Interventions
DRUG

EGCG, FA, HA, B12

Epigallocatechin gallate 200mg, Hyaluronic acid 50mg, Vitamin B12 1mg, Folic acid 400mcg

Trial Locations (1)

73020

Ospedale Veris delli Ponti, Scorrano

All Listed Sponsors
lead

Centro di Ricerca Clinica Salentino

NETWORK

NCT06098456 - Epigallocatechin Gallate and Other Antural Compounds in HPV Infections | Biotech Hunter | Biotech Hunter